Viewing Study NCT03108495


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-01-24 @ 5:41 PM
Study NCT ID: NCT03108495
Status: TERMINATED
Last Update Posted: 2025-09-17
First Post: 2017-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Sponsor: Iovance Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module